The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.91BCNY
433.93M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
450.00x
vs Conglomerates peers
Updated Sep 21, 2026
Revenue (TTM)
750.93MCNY
112.14M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
0.98%
vs Conglomerates peers
Updated Sep 21, 2026
Beta
0.4370x
vs all stocks
Updated Sep 21, 2026
52-Week Change
-16.08%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
2.91BCNY
433.93M · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
3.11BCNY
463.73M · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
450.00x
vs Conglomerates peers
Updated Sep 21, 2026
Price to Sales (TTM)
3.75x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 3.87×.Updated Sep 21, 2026
Price to Book (MRQ)
2.61x
vs Conglomerates peers
Updated Sep 21, 2026
Enterprise to Revenue
4.13x
vs Conglomerates peers
Updated Sep 21, 2026
Enterprise to EBITDA
26.16x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 23.21×.Updated Sep 21, 2026
Gross Margin
25.80%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 27.98%.Updated Sep 21, 2026
Profit Margin
0.98%
vs Conglomerates peers
Updated Sep 21, 2026
Operating Margin
11.83%
vs Conglomerates peers
Updated Sep 21, 2026
Return on Assets (TTM)
3.23%
vs Conglomerates peers
Updated Sep 21, 2026
Return on Equity (TTM)
5.67%
vs Conglomerates peers
Updated Sep 21, 2026
Revenue (TTM)
750.93MCNY
112.14M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
2.32CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
17.20%
vs Conglomerates peers
Updated Sep 21, 2026
Gross Profit (TTM)
210.11MCNY
31.38M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
133.81MCNY
19.98M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
7.34MCNY
1.10M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
-58.90%
vs Conglomerates peers
Updated Sep 21, 2026
Operating Cash Flow (TTM)
138.93MCNY
20.75M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
85.86MCNY
12.82M · vs all stocks (USD)
Updated Sep 21, 2026
5-Year Average Dividend Yield
0.28%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Sep 21, 2026
Minority Interest (Equity)
199.63MCNYFY2025 · Dec 31, 2025
Revenue
744.74MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
534.41MCNYFY2025 · Dec 31, 2025
Gross Profit
210.33MCNYFY2025 · Dec 31, 2025
Operating Income
86.28MCNY
12.88M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
72.58MCNYFY2025 · Dec 31, 2025
Income Tax Expense
24.31MCNYFY2025 · Dec 31, 2025
Net Income
48.28MCNYFY2025 · Dec 31, 2025
EBIT
91.02MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
133.81MCNYFY2025 · Dec 31, 2025
Research & Development
7.47MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
43.99MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
7.58MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.10MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
18.44MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0300CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0300CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
294.75MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
294.75MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
48.28MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-39.43MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
76.66MCNYFY2025 · Dec 31, 2025
Free Cash Flow
55.20MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
454.57MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
48.28MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
29.78MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
5.27MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-6.67MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-21.46MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-392.90MCNYFY2025 · Dec 31, 2025
Sale of Investments
423.39MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-444.90KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
8.59MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
518.00MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-496.55MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-6.28MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-43.36MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-28.18MCNYFY2025 · Dec 31, 2025
Shares Outstanding
312.79MSharesUpdated Sep 21, 2026
Float Shares
161.54MSharesUpdated Sep 21, 2026
% Held by Insiders
54.49%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
1.88%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
403.24MCNY
60.22M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
1.29CNYUpdated Sep 21, 2026
Total Debt (MRQ)
513.12MCNY
76.62M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.6360x
vs Conglomerates peers
Updated Sep 21, 2026
Current Ratio (MRQ)
1.57x
vs Conglomerates peers
Updated Sep 21, 2026
Book Value per Share (MRQ)
3.44CNYUpdated Sep 21, 2026
Total Assets
1.79BCNY
266.82M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
757.64MCNYFY2025 · Dec 31, 2025
Total Liabilities
977.85MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.03BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
487.09MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
490.76MCNYFY2025 · Dec 31, 2025
Cash
453.11MCNYFY2025 · Dec 31, 2025
Cash Equivalents
5.59MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
458.70MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
20.01MCNYFY2025 · Dec 31, 2025
Accounts Receivable
156.32MCNYFY2025 · Dec 31, 2025
Inventory
48.02MCNYFY2025 · Dec 31, 2025
Accounts Payable
271.86MCNYFY2025 · Dec 31, 2025
Short-term Debt
107.59MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
3.71MCNYFY2025 · Dec 31, 2025
Long-term Debt
404.91MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
310.59MCNYFY2025 · Dec 31, 2025
Retained Earnings
188.86MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
808.93MCNY
120.80M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
7.47CNYUpdated Sep 21, 2026
52-Week High
16.08CNYUpdated Sep 21, 2026
52-Week Change
-16.08%
vs all stocks
Updated Sep 21, 2026
Beta
0.4370x
vs all stocks
Updated Sep 21, 2026
50-Day MA
8.79CNYUpdated Sep 21, 2026
200-Day MA
10.37CNYUpdated Sep 21, 2026
Avg 10-Day Volume
16.91MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
22.33MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
0.0200CNYUpdated Sep 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 450×, higher than 95% of its Conglomerates peers (median 20.09×)Significant